﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Genrated: Wed, 06 May 2026 13:07:48 GMT--><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:ev="http://purl.org/rss/1.0/modules/event/"><channel><title>American Pharmacists Association</title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/November-2022/rss/3540</link><atom:link href="http://www.pharmacist.com/Publications/Pharmacy-Today/November-2022/rss/3540" rel="self" type="application/rss+xml" /><description>RSS document</description><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Inpatient Insights]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/inpatient-insights-55</link><description><![CDATA[  APhA Staff  

 Oseltamivir seems to shorten hospital stays for kids with flu 

   

 Influenza is common among children and as many as 45,000 of those patients end up in the hospital. ...]]></description><pubDate>Fri, 07 Oct 2022 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/inpatient-insights-55</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3402]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Preparing for new USP &lt;797&gt; updates]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/preparing-for-new-usp-797-updates</link><description><![CDATA[  Clarissa Chan, PharmD  

   

 Pharmacists should be gearing up for changes to USP Chapter 797–Sterile Preparations. USP published proposed revisions to   in early September 2021 and welcomed ...]]></description><pubDate>Fri, 07 Oct 2022 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/preparing-for-new-usp-797-updates</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3398]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Burden of prior authorization lifted by specialty pharmacy practice]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/burden-of-prior-authorization-lifted-by-specialty-pharmacy-practice</link><description><![CDATA[  Ariel L. Clark, PharmD       

   

 “Your prescription requires prior authorization.” A statement heard far and wide across the health care system and one that pharmacists and pharmacy ...]]></description><pubDate>Fri, 07 Oct 2022 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/burden-of-prior-authorization-lifted-by-specialty-pharmacy-practice</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3399]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Endocrine Society releases updated guideline for inpatient management of hyperglycemia]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/endocrine-society-releases-updated-guideline-for-inpatient-management-of-hyperglycemia</link><description><![CDATA[  Olivia C. Welter, PharmD  

 Hyperglycemia is a common occurrence in hospitalized patients whether they have diabetes or not. Patients with diabetes account for nearly 25% of inpatients, and up ...]]></description><pubDate>Fri, 07 Oct 2022 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/endocrine-society-releases-updated-guideline-for-inpatient-management-of-hyperglycemia</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3400]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Researchers examine metformin, ivermectin, and fluvoxamine for COVID-19 treatment]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/researchers-examine-metformin-ivermectin-and-fluvoxamine-for-covid-19-treatment</link><description><![CDATA[  Corey Diamond, PharmD  

   

 As the COVID-19 pandemic surges on, the public has seen the rise and fall of several promising therapeutic agents for COVID-19 outpatient treatment. These agents ...]]></description><pubDate>Fri, 07 Oct 2022 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/researchers-examine-metformin-ivermectin-and-fluvoxamine-for-covid-19-treatment</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3401]]></dc:identifier></item></channel></rss>